Founded in Oxford in 2016, Arctoris is the world’s first fully automated drug discovery platform.
A global team of biotech and pharma veterans and leading engineers developed and operate our proprietary technology platform. Arctoris is the next step in drug discovery data generation, offering fully automated Experiments-as-a-Service.
With millions suffering from chronic illnesses, the world continues to be in desperate need of novel and better therapies to improve and extend lives. However, bringing new drugs to the market remains slow and expensive, with lack of reproducibility and outdated processes obscuring the path to approval.
At Arctoris, we utilise advanced technology to reinvent R&D process: embracing end-to-end automation, we generate superior quality data on demand, enable full metadata capture, expedite project timelines and empower our partners and clients to gain the insights they need, delivered at speed. Ultimately, this translates to bringing better treatments for those in need, faster.
Arctoris Celebrates 5th Anniversary and Launches Its Expanded Robotic Platform Ulysses
Intellegens' machine learning software Alchemite™ is helping to catalyze innovation within key sectors within the chemical, manufacturing and pharmaceutical industries.
AZoRobotics speaks to Prof Matt Reed, Strategy Director for the Materials Innovation Factory at the University of Liverpool, about how the application of industry 4.0 technologies such as robotics and automation can unlock chemistry and advanced materials research and innovation.
A start-up robotics company based in New York, US is manufacturing an innovative “histotechnician” robot to revolutionize lab methods.
This page discusses Celera Motion’s Capitan Series to their line of premium performance Ingenia servo drives.
This page details the capabilities of the TeraRanger Evo Mini, a single- and multi-pixel capability in one sensor.
The basis of the fiber alignment system is a very stiff set-up consisting of the H-811 hexapod and P-616 NanoCube® nanopositioner.